The Cigna Group upgraded by Cantor Fitzgerald with a new price target
$CI
Medical Specialities
Health Care
Cantor Fitzgerald upgraded The Cigna Group from Neutral to Overweight and set a new price target of $372.00 from $334.00 previously
Get the next $CI alert in real time by email
Get the next $CI alert in real time by email
Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $CI
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/6/2025 | $323.00 | Outperform → Mkt Perform | Bernstein |
| 6/26/2024 | $400.00 | Overweight | Piper Sandler |
| 5/30/2024 | $388.00 | Outperform | Robert W. Baird |
| 3/6/2024 | $393.00 | Overweight | Barclays |
| 2/5/2024 | $334.00 → $372.00 | Neutral → Overweight | Cantor Fitzgerald |
| 2/5/2024 | $327.00 → $354.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 2/1/2024 | $355.00 → $370.00 | Hold → Buy | Deutsche Bank |
| 1/4/2024 | $330.00 → $372.00 | Mkt Perform → Outperform | Bernstein |
The Cigna Group Completes Sale of Medicare Businesses to HCSC
BLOOMFIELD, Conn., March 19, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today announced the successful completion of the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC). The divestment of these assets streamlines The Cigna Group's portfolio and enables it to drive further innovation to support customers. As previously announced, proceeds from the sale will be used in alignment with The Cigna Group's capital deployment priorities, with the majority expecte
The Cigna Group announces leadership changes to accelerate the company's growth strategy
Brian Evanko named President and Chief Operating Officer, The Cigna GroupAnn Dennison named Executive Vice President and Chief Financial Officer, The Cigna GroupNicole Jones, Chief Administrative Officer and General Counsel, to assume oversight of Enterprise MarketingEric Palmer, President and Chief Executive Officer of Evernorth Health Services, to depart The Cigna GroupReaffirms Full Year 2025 Financial Outlook BLOOMFIELD, Conn., March 13, 2025 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to further drive the company's focus on customers and patients and accelerate its growth strategy.
The Cigna Group Announces Appearance at Barclays 27th Annual Global Healthcare Conference
BLOOMFIELD, Conn., Feb. 26, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, EVP and CFO of The Cigna Group, and President and CEO of Cigna Healthcare, will present at Barclays 27th Annual Global Healthcare Conference on March 12, 2025, through a virtual webcast. The Cigna Group's presentation is expected to begin at approximately 2:00 p.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Grou
The Cigna Group downgraded by Bernstein with a new price target
Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00
Piper Sandler initiated coverage on The Cigna Group with a new price target
Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00
Robert W. Baird initiated coverage on The Cigna Group with a new price target
Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00
Director Granger Elder exercised 2,376 shares at a strike of $151.48 and sold $737,392 worth of shares (2,376 units at $310.35) (SEC Form 4)
4 - Cigna Group (0001739940) (Issuer)
Officer Eder Noelle K sold $3,182,080 worth of shares (9,944 units at $320.00), decreasing direct ownership by 43% to 13,406 units (SEC Form 4)
4 - Cigna Group (0001739940) (Issuer)
Officer Palmer Eric P was granted 21,377 shares and covered exercise/tax liability with 9,490 shares, increasing direct ownership by 22% to 66,160 units (SEC Form 4)
4 - Cigna Group (0001739940) (Issuer)
SEC Form 144 filed by The Cigna Group
144 - Cigna Group (0001739940) (Subject)
The Cigna Group filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Cigna Group (0001739940) (Filer)
SEC Form DEFA14A filed by The Cigna Group
DEFA14A - Cigna Group (0001739940) (Filer)
The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement
As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to
The Cigna Group announces leadership changes to continue driving growth
Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.
The Cigna Group Announces Appointment of Dr. Philip Ozuah to Board of Directors
BLOOMFIELD, Conn., May 1, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023. CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023." alt="The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023."> Since 2019, Dr. Philip Oz
The Cigna Group announces leadership changes to accelerate the company's growth strategy
Brian Evanko named President and Chief Operating Officer, The Cigna GroupAnn Dennison named Executive Vice President and Chief Financial Officer, The Cigna GroupNicole Jones, Chief Administrative Officer and General Counsel, to assume oversight of Enterprise MarketingEric Palmer, President and Chief Executive Officer of Evernorth Health Services, to depart The Cigna GroupReaffirms Full Year 2025 Financial Outlook BLOOMFIELD, Conn., March 13, 2025 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to further drive the company's focus on customers and patients and accelerate its growth strategy.
The Cigna Group Reports Fourth Quarter and Full Year 2024 Results, Establishes 2025 Outlook and Increases Dividend
Total revenues for 2024 increased 27% to $247.1 billionShareholders' net income for 2024 was $3.4 billion, or $12.12 per shareAdjusted income from operations1 for 2024 was $7.7 billion, or $27.33 per share2025 adjusted income from operations1,2 is projected to be at least $7.9 billion, or at least $29.50 per shareBoard of Directors declared an 8% increase in the quarterly dividend to $1.51 per share and approved an increase of $6.0 billion in incremental share repurchase authorization, bringing total authorization to $10.3 billionBLOOMFIELD, Conn., Jan. 30, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported 2024 results, reflecting continued strength in Ever
The Cigna Group's Fourth Quarter 2024 Earnings Release Details
BLOOMFIELD, Conn., Jan. 14, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a conference call the same day. Fourth quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 01302025 Replay(800) 819-5739 (Domestic)(203) 369-3350 (Inter
SEC Form SC 13G filed by The Cigna Group
SC 13G - Cigna Group (0001739940) (Subject)
SEC Form SC 13G/A filed by The Cigna Group (Amendment)
SC 13G/A - Cigna Group (0001739940) (Subject)
SEC Form SC 13G/A filed by The Cigna Group (Amendment)
SC 13G/A - Cigna Group (0001739940) (Subject)